A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia

NCT05743465 · clinicaltrials.gov ↗
COMPLETED
Status
1769
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda